Zhou Yaguan, You Yating, Zhang Yuting, Zhang Yue, Yuan Changzheng, Xu Xiaolin
School of Public Health, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China; The Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province, Hangzhou, Zhejiang, PR China.
School of Public Health, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China; The Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province, Hangzhou, Zhejiang, PR China; School of Public Health, Faculty of Medicine, The University of Queensland, Brisbane, Australia.
J Prev Alzheimers Dis. 2025 Apr 16:100164. doi: 10.1016/j.tjpad.2025.100164.
Chronic diseases (e.g., hypertension, diabetes, and heart diseases) have been proposed as marked predictors of incident dementia. However, synthesised evidence on the effect of multimorbidity on dementia is still lacking. We aim to summarise the association between multimorbidity and risk of dementia in longitudinal cohorts.
In this systematic review and meta-analysis, we conducted a systematic search in PubMed, Web of Science and Embase from inception to Dec 14, 2024, to identify longitudinal cohort studies reporting the association between multimorbidity or multimorbidity patterns and risk of dementia. Information of included studies were extracted by three reviewers (YaZ, YY and YuZ), and the quality assessment was conducted using the Newcastle-Ottawa Scale. The inverse-variance weighted random effects meta-analysis was performed to obtain the pooled hazard ratios (HRs) and 95 % confidence intervals (CIs) for dementia associated with multimorbidity and cardiometabolic multimorbidity (CMM). Cochran's Q test and the I statistic were used to indicate heterogeneity among the studies. Meta-regression analysis, subgroup analysis and sensitivity analysis were conducted to determine any valid sources of heterogeneity. This study was registered with PROSPERO (CRD42023403684).
We included 17 longitudinal cohort studies (2262,885 middle-aged and older participants) in the systematic review, of which seven were included in meta-analysis. All studies presented moderate to high methodological quality. Meta-analysis showed a positive association between multimorbidity and incident dementia (HR=1.53, 95 % CI=1.12 to 2.09), with substantial heterogeneity (I=95.2 %). Studies using health records to measure dementia tend to find a stronger positive relationship between multimorbidity and risk of dementia than those using self-report (HR=1.94, 95 % CI=1.35 to 2.78, I=94 %; HR=1.17, 95 % CI=1.07 to 1.28, I=0 %). The impacts of CMM were also observed, and the HRs for dementia ranged from 2.49 (combination of heart diseases and stroke: 95 % CI=1.64 to 3.78) to 3.77 (combination of diabetes, heart diseases and stroke: 95 % CI=2.02 to 7.02). The heterogeneity was moderate, with I ranging from 46.9 % (p for heterogeneity=0.152) to 84.1 % (p for heterogeneity=0.002). The impacts of number of diseases, multimorbidity clusters, and multimorbidity trajectory on risk of dementia were narratively summarised due to lacking comparable studies. Limited evidence (only one study) precluded quantitative synthesis for the association of physical and psychological multimorbidity with dementia.
Multimorbidity and CMM pattern were significantly associated with risk of dementia, while the effect of physical and psychological multimorbidity remain inconclusive. Individuals affected by multimorbidity should be prioritised in risk factor modification and dementia prevention. Preventing the development of multimorbidity is also crucial-particularly those who already have one chronic disease-in order to maintain cognitive health.
慢性病(如高血压、糖尿病和心脏病)已被认为是新发痴呆症的显著预测因素。然而,关于多病共存对痴呆症影响的综合证据仍然缺乏。我们旨在总结纵向队列研究中多病共存与痴呆症风险之间的关联。
在这项系统评价和荟萃分析中,我们从数据库建立至2024年12月14日在PubMed、Web of Science和Embase中进行了系统检索,以识别报告多病共存或多病共存模式与痴呆症风险之间关联的纵向队列研究。纳入研究的信息由三位审阅者(YaZ、YY和YuZ)提取,并使用纽卡斯尔-渥太华量表进行质量评估。采用逆方差加权随机效应荟萃分析,以获得与多病共存和心血管代谢多病共存(CMM)相关的痴呆症的合并风险比(HR)和95%置信区间(CI)。采用Cochran's Q检验和I统计量来表明研究之间的异质性。进行了荟萃回归分析、亚组分析和敏感性分析,以确定异质性的任何有效来源。本研究已在国际前瞻性系统评价注册库(PROSPERO)注册(CRD42023403684)。
我们在系统评价中纳入了17项纵向队列研究(2262885名中老年参与者),其中7项纳入了荟萃分析。所有研究均呈现出中等到高质量的方法学。荟萃分析显示,多病共存与新发痴呆症之间存在正相关(HR=1.53,95%CI=1.12至2.09),异质性较大(I=95.2%)。与使用自我报告的研究相比,使用健康记录来衡量痴呆症的研究往往发现多病共存与痴呆症风险之间存在更强的正相关(HR=1.94,95%CI=1.35至2.78,I=94%;HR=1.17,95%CI=1.07至1.28,I=0%)。还观察到了CMM的影响,痴呆症的HR范围为2.49(心脏病和中风的组合:95%CI=1.64至3.78)至3.77(糖尿病、心脏病和中风的组合:95%CI=2.02至7.02)。异质性为中等,I范围为46.9%(异质性p值=0.152)至84.1%(异质性p值=0.002)。由于缺乏可比研究,对疾病数量、多病共存集群和多病共存轨迹对痴呆症风险的影响进行了叙述性总结。有限的证据(仅一项研究)排除了对身体和心理多病共存与痴呆症关联进行定量综合分析的可能性。
多病共存和CMM模式与痴呆症风险显著相关,而身体和心理多病共存的影响仍无定论。受多病共存影响的个体应在风险因素调整和痴呆症预防中被优先考虑。预防多病共存的发展也至关重要,特别是对于那些已经患有一种慢性病的人,以维持认知健康。